With all the focus on the COVID-19 vaccine, it is time to review the updates in treatment. We trust that all our hospitals are using evidence-based protocols to determine which patients will benefit the most from the various treatment options out there.

 

What therapies might help people with severe COVID-19 before hospitalization?
In November 2020, the Food and Drug Administration (FDA) granted the emergency use of two monoclonal antibody treatments. One is called Bamlanivimab, and the other is a combination of casirivimab and imdevimab. These treatments are for non-hospitalized adults and children over twelve with moderate COVID-19 symptoms who are at risk of developing severe COVID-19 symptoms or being hospitalized. These drugs are given intravenously by an IV soon after
developing symptoms.

 

 

 

 

 

 

 

 

 

 

 

 

What medications can doctors use for people hospitalized with COVID-19?
Dexamethasone and other corticosteroids (prednisone, methylprednisolone) are potent anti-inflammatory drugs. These drugs are readily available and inexpensive. They are widely used for patients with asthma, sarcoidosis, and rheumatoid arthritis.
Patients who required supplemental oxygen or ventilators and who received dexamethasone were less likely to die within 28 days than those who received standard care. This recommendation was based on a clinical trial from the NIH.


Remdesivir
In October 2020, the FDA approved the antiviral drug remdesivir to treat COVID-19. The drug may be used to treat adults and children ages 12 and older, weighing at least 88 pounds, and who has been hospitalized for COVID-19. Clinical trials suggest that in these patients, remdesivir may modestly speed up recovery time.

 

Baricitinib in combination with remdesivir
In November 2020, the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to use baricitinib in combination with remdesivir in hospitalized adults and children 2 years and older who require respiratory support.

Ultimately, it takes patients presenting to the health care center in a timely manner so that treatments can reverse the symptoms of the virus. It also takes physicians being aware of the treatment protocols and being aggressive with patients who are too weak to advocate for themselves.

 

To learn more on the Harvard University Coronavirus Resource Center website, click here.

The Public’s Eagerness to Get a Vaccine is Rising Across Racial and Ethnic Groups

The share of U.S. adults who want to get the vaccine as soon as possible has increased since December among Black, Hispanic, and White adults alike, and the share who say they want to “wait and see” how it works for other people has declined among Black and White adults. However, Black adults (43%) and Hispanic adults (37%) remain significantly more likely than White adults (26%) to say they want to “wait and see,” while White adults (53%) are more likely to say they have already been vaccinated or want the vaccine “as soon as possible” compared Black or Hispanic adults (35% and 42%, respectively).

The American Heart Association: COVID-19 Response

The American Heart Association is working with researchers, medical experts, hospitals, community leaders, businesses and ...

Meet the Black Female Scientist at the Forefront of COVID-19 Vaccine Development

January 2021 When President Donald Trump paid a visit to the National Institutes of Health ...

 

About Uzima
Magazine
Contact Us

© 2020 - 2021 Uzima Health & Wellness.

All rights reserved. Managed By NobleSol Art Group

Get in Touch